Cargando…
Autoinhibition of the GEF activity of cytoskeletal regulatory protein Trio is disrupted in neurodevelopmental disorder-related genetic variants
TRIO encodes a cytoskeletal regulatory protein with three catalytic domains—two guanine exchange factor (GEF) domains, GEF1 and GEF2, and a kinase domain—as well as several accessory domains that have not been extensively studied. Function-damaging variants in the TRIO gene are known to be enriched...
Autores principales: | Bircher, Josie E., Corcoran, Ellen E., Lam, TuKiet T., Trnka, Michael J., Koleske, Anthony J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467883/ https://www.ncbi.nlm.nih.gov/pubmed/35963430 http://dx.doi.org/10.1016/j.jbc.2022.102361 |
Ejemplares similares
-
Trio Haploinsufficiency Causes Neurodevelopmental Disease–Associated Deficits
por: Katrancha, Sara Marie, et al.
Publicado: (2019) -
On the mechanism of autoinhibition of the RhoA-specific nucleotide exchange factor PDZRhoGEF
por: Zheng, Meiying, et al.
Publicado: (2009) -
Serine phosphorylation of the RhoGEF Trio stabilizes endothelial cell-cell junctions
por: Daniel, Anna E., et al.
Publicado: (2023) -
Analysis of trio test in neurodevelopmental disorders
por: Kim, Se Hee, et al.
Publicado: (2022) -
Viral Activation of MK2-hsp27-p115RhoGEF-RhoA Signaling Axis Causes Cytoskeletal Rearrangements, P-body Disruption and ARE-mRNA Stabilization
por: Corcoran, Jennifer A., et al.
Publicado: (2015)